RAPID DIAGNOSTIC TESTING (RDT) TRAINING
Diagnostic testing is used to identify individuals infected with Severe Acute Respiratory Syndromecoronavirus-2 (SARS–CoV-2) which plays an important role in the control of the COVID-19 pandemic. It enables diagnosis of cases to guide clinical management, facilitates identification of cases for isolation to reduce transmission and provides estimates of prevalence at the population level to guide intervention implementation and resource planning. Fast, efficient and timely testing is a vital prerequisite for early identification and reporting of COVID-19. Coupled with adequate contact tracing, isolation of cases and quarantine of contacts, testing is critical in preventing transmission and slowing down the spread of SARS-CoV-2.
There are several testing methods for SARS-CoV-2. Molecular tests detect the viral RNA in pharyngeal swabs (nasal or oral), with varied range of the manual and automated machine platforms available in the testing laboratories. Serological tests which detect either viral antigens in patient’s blood or patient’s antibodies against SARSCoV-2 are also commercially available.
This training was organized to build capacity of testing sites on Rapid Diagnostic Testing for COVID-19.
What Will I Learn?
- Prompt clinical management of cases with COVID-19 symptoms at admission.
- Control Transmission: early detection of cases, contact tracing, population-wide testing.
- Mitigate the impact of COVID-19 in healthcare and social-care settings: triage at admission, early detection and isolation.
- Identify clusters or outbreaks in specific settings: early detection and isolation.